Drugs / Proliverenol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06127225 | Apr 2023 → Aug 2024 | NAFLD1 | Dexa Medica Group | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Proliverenol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06127225 ↗ |